Harmony Biosciences (HRMY) News Today → Do This Today BEFORE Biden Wins in November (From Stansberry Research) (Ad) Free HRMY Stock Alerts $30.14 -1.14 (-3.64%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLSV Asset Management Acquires Shares of 75,053 Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)marketbeat.com - May 10 at 7:01 AMHarmony Biosciences Expands into Rare Epilepsy Market with Epygenix Therapeutics Acquisitionmsn.com - May 6 at 2:09 AMResults: Harmony Biosciences Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecastsfinance.yahoo.com - May 4 at 4:55 PMHarmony Biosciences Holdings First Quarter 2024 Earnings: EPS Beats Expectationsfinance.yahoo.com - May 3 at 10:49 AMLooking for a Growth Stock? 3 Reasons Why Harmony Biosciences is a Solid Choicemarkets.businessinsider.com - May 2 at 3:30 PMHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2024 Earnings Call Transcriptmsn.com - May 2 at 10:29 AMHarmony Biosciences Holdings Inc (HRMY) Q1 2024 Earnings Call Transcript Highlights: Strong ...finance.yahoo.com - May 1 at 7:01 PMEasterly Government Properties, Inc. (NYSE:DEA) Q1 2024 Earnings Call Transcriptmsn.com - May 1 at 2:01 PMHarmony Biosciences (NASDAQ:HRMY) Releases Earnings Results, Beats Expectations By $0.07 EPSmarketbeat.com - May 1 at 12:50 PMHarmony Biosciences' (HRMY) Buy Rating Reaffirmed at Needham & Company LLCamericanbankingnews.com - May 1 at 4:14 AMRapidly Growing Harmony Biosciences Sees 30% Increase in Net Revenue, Boosts Growth Strategy With Rare Epilepsy Franchise Acquisitionmsn.com - April 30 at 10:59 PMHarmony Biosciences shares soar on acquisition of New Jersey epilepsy drug developerbizjournals.com - April 30 at 5:59 PMHarmony Biosciences (HRMY) Q1 2024 Earnings Call Transcriptfool.com - April 30 at 5:59 PMJackson Creek Investment Advisors LLC Takes $991,000 Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)marketbeat.com - April 30 at 5:35 PMHarmony Biosciences: Company's Q1 Update Music To Investor Ears (Upgrade)seekingalpha.com - April 30 at 4:00 PMHarmony Biosciences Buys Epygenix Therapeutics For Initial $35 Millionmarketwatch.com - April 30 at 12:58 PMHarmony Biosciences Shares Rise After Earnings, Acquisitionmarketwatch.com - April 30 at 12:58 PMAnalysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), Moderna (MRNA) and Ionis Pharmaceuticals (IONS)markets.businessinsider.com - April 30 at 12:58 PMKey Takeaways From Harmony Biosciences Analyst Ratingsmarkets.businessinsider.com - April 30 at 12:58 PMHRMY Stock Earnings: Harmony Biosciences Beats EPS, Misses Revenue for Q1 2024msn.com - April 30 at 12:58 PMHarmony Biosciences Exceeds Analyst Revenue Forecasts While Aligning with EPS Projections in Q1 2024finance.yahoo.com - April 30 at 12:58 PMHarmony Biosciences (NASDAQ:HRMY) Shares Gap Up to $29.25marketbeat.com - April 30 at 12:31 PMHarmony Biosciences Holdings, Inc. 2024 Q1 - Results - Earnings Call Presentationseekingalpha.com - April 30 at 12:03 PMHarmony Biosciences' (HRMY) Buy Rating Reiterated at Needham & Company LLCmarketbeat.com - April 30 at 9:14 AMHarmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsyglobenewswire.com - April 30 at 7:05 AMHarmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assetsprnewswire.com - April 30 at 7:00 AMHarmony Biosciences earnings: here's what Wall Street expectsmarkets.businessinsider.com - April 29 at 2:08 PMHarmony Biosciences Q1 2024 Earnings Previewmsn.com - April 29 at 2:08 PMHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Purchased by Paradiem LLCmarketbeat.com - April 28 at 1:50 PMabrdn plc Sells 48,455 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)marketbeat.com - April 25 at 6:14 AMHarmony Biosciences (HRMY) Set to Announce Quarterly Earnings on Tuesdaymarketbeat.com - April 23 at 6:31 AMHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Position Boosted by Federated Hermes Inc.marketbeat.com - April 23 at 5:35 AMHarmony Biosciences to Unveil Q1 2024 Financial Resultsmsn.com - April 22 at 10:22 AMHealthInvest Partners AB Takes $4.68 Million Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)marketbeat.com - April 16 at 6:41 PMHARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024finance.yahoo.com - April 16 at 11:07 AMHarmony Biosciences Secures Exclusive Rights to Promising Narcolepsy Treatmentmsn.com - April 15 at 1:36 PMHarmony Biosciences secures rights to narcolepsy treatmentinvesting.com - April 12 at 11:49 PMHarmony Biosciences (NASDAQ:HRMY) Stock Rating Reaffirmed by Cantor Fitzgeraldmarketbeat.com - April 12 at 10:22 AMHarmony inks licensing deal for sleep disorder therapymsn.com - April 11 at 3:00 PMHarmony Biosciences (NASDAQ:HRMY) Stock Price Up 4.7%marketbeat.com - April 11 at 2:49 PMHARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONISTfinance.yahoo.com - April 11 at 9:59 AMHARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONISTprnewswire.com - April 11 at 8:05 AMHarmony Biosciences (NASDAQ:HRMY) Receives Buy Rating from Needham & Company LLCmarketbeat.com - April 9 at 8:30 AMHarmony Biosciences Launches Phase 3 Trial for Potential Prader-Willi Syndrome Treatmentmsn.com - April 8 at 3:55 PMHarmony Biosciences (NASDAQ:HRMY) Sees Unusually-High Trading Volumemarketbeat.com - April 8 at 1:45 PMVanguard Group Inc. Grows Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)marketbeat.com - April 4 at 4:11 AMHARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROMEfinance.yahoo.com - April 3 at 12:33 PMHarmony Biosciences to Spotlight Innovations at Needham Virtual Healthcare Conferencemsn.com - April 1 at 7:52 PMEvaluating Harmony Biosciences: Insights From 8 Financial Analystsmarkets.businessinsider.com - March 28 at 4:42 PMHarmony Biosciences' (HRMY) Overweight Rating Reaffirmed at Cantor Fitzgeraldmarketbeat.com - March 28 at 11:51 AM Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Email Address “Crash Insurance” For Your Retirement (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. HRMY Media Mentions By Week HRMY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HRMY News Sentiment▼1.550.52▲Average Medical News Sentiment HRMY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HRMY Articles This Week▼54▲HRMY Articles Average Week Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Schrödinger News Catalyst Pharmaceuticals News Syndax Pharmaceuticals News Agios Pharmaceuticals News Structure Therapeutics News Evotec News Edgewise Therapeutics News Amneal Pharmaceuticals News Supernus Pharmaceuticals News Avadel Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HRMY) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable ProsperityYou need to know these two things about AI stocks ASAP…InvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harmony Biosciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
